OKYO Pharma Limited, (OKYO): Price and Financial Metrics
OKYO Price/Volume Stats
Current price | $1.04 | 52-week high | $1.90 |
Prev. close | $1.05 | 52-week low | $0.81 |
Day low | $1.02 | Volume | 64,300 |
Day high | $1.06 | Avg. volume | 140,309 |
50-day MA | $1.08 | Dividend yield | N/A |
200-day MA | $1.20 | Market Cap | 35.19M |
OKYO Stock Price Chart Interactive Chart >
OKYO Pharma Limited, (OKYO) Company Bio
OKYO Pharma Limited, a preclinical biopharmaceutical company, engages in developing therapeutics for patients suffering from inflammatory eye diseases and ocular pain in the United Kingdom. It is developing OK-101 for the treatment of dry eye disease; and OK-201, a bovine adrenal medulla, lipidated-peptide preclinical analogue candidate for the treatment of neuropathic ocular pain. The company is also developing chemerin and chemerin analogues to treat the cytokine release syndrome associated with COVID-19 infections and other conditions, such as acute respiratory distress syndrome. OKYO Pharma Limited was incorporated in 2007 and is headquartered in London, the United Kingdom.
OKYO Price Returns
1-mo | -1.89% |
3-mo | -15.45% |
6-mo | -22.96% |
1-year | -35.40% |
3-year | N/A |
5-year | N/A |
YTD | -9.56% |
2024 | -35.03% |
2023 | -7.33% |
2022 | N/A |
2021 | N/A |
2020 | N/A |
Loading social stream, please wait...